Defibrotide in the Human Endotoxemia Model - an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Defibrotide (Primary) ; Lipopolysaccharide (Primary)
- Indications Diabetic nephropathies; Graft-versus-host disease; Veno-occlusive disorders
- Focus Pharmacodynamics
- Acronyms LPS_DF
- 22 Mar 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.
- 22 Mar 2017 Planned initiation date changed from 1 Sep 2016 to 1 Apr 2017.
- 08 Sep 2016 New trial record